全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2018 

甲状腺癌术后行IVF/ICSI-ET助孕临床结局
Clinical outcomes of IVF/ICSI-ET after thyroid cancer surgical treatment

DOI: 10.6040/j.issn.1671-7554.0.2018.516

Keywords: 甲状腺癌,新生儿甲状腺功能减退症,体外受精-胚胎移植,促甲状腺激素,妊娠期并发症,
Thyroid cancer
,Thyroid-stimulating hormone,In vitro fertilization/follicle intracytoplasmic sperm injection-embryo transfer,Gestational diabetes,Neonatal hypothyroidism

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]  中华医学会内分泌学分会,中华医学会围产医学分会.妊娠和产后甲状腺疾病诊治指南[J]. 中华内分泌代谢杂志, 2012, 28(7): 354-371.
[2]  刘彩霞,吴爱红. 妊娠期甲状腺疾病的认知和筛查状况[J]. 中华围产医学杂志, 2015, 18(3): 229-231.
[3]  韩彦青, 叶飘, 石境懿. 母体甲减与新生儿甲减的关系及TSH达标治疗对患儿甲减发病率的影响[J]. 西部医学, 2017, 29(5): 647-651. HAN Yanqing, YE Piao, SHI Jingyi. Study on the relationship between maternal hypothyroidism and neonatal hypothyroidism and the effect of TSH goal-directed therapy on the incidence of hypothyroidism in children[J]. West China, 2017, 29(5): 647-651.
[4]  赵军育. 新生儿生后甲状腺功能检查及影响因素分析[J]. 继续医学教育, 2017, 31(9): 115-117.
[5]  陈小芸. 4年剖宫产率及剖宫产手术指征变化研究[D].福州: 福建医科大学, 2017.
[6]  Vivacqua A, Bonofiglio D, Albanito L, et al. 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30[J]. Mol Pharmacol, 2006, 70(4): 1414-1423.
[7]  肖海群. 甲状腺功能减退对妊娠及其结局的影响[J]. 中国现代医学杂志, 2012, 22(18): 53-57. XIAO Haiqun. Influence of hypothyroidism on pregnancy and its outcomes[J]. China Journal of Modern Medicine, 2012, 22(18): 53-57.
[8]  陈敦芝, 何云琴, 张治洋. 甲状腺功能异常与妊娠期糖尿病及妊娠期高血压的相关性[J]. 西南国防医药, 2017, 27(11): 1224-1226.
[9]  张钧, 李鸣, 李平. 手术治疗125例分化性甲状腺癌的5年随访结果分析[J]. 西南国防医药, 2007, 17(4): 420-422. ZHANG Jun, LI Ming, LI Ping. Five-years following- up results of surgical treatment of 125 cases with differentiated thyroid carcinoma[J]. Medical Journal of National Defending Forces in Southwest China, 2007, 17(4): 420-422.
[10]  Gardner DK, Lane M, Stevens J, et al. Blastocyst score affects implantation and pregnancy out-come: towards a single blastocyst transfer[J]. Fertil Steril, 2000, 73(6): 1155-1158.
[11]  吴孟超,吴在德,吴肇汉. 外科学[M]. 8版. 北京:人民卫生出版社,2013.
[12]  张艳馨,姚丽芬,冒韵东, 等. 促甲状腺激素(TSH)水平对IVF/ICSI妊娠结局的影响[J]. 生殖与避孕, 2012, 32(1): 17-23. ZHANG Yanxin, YAO Lifen, MAO Yundong, et al. Correlation of thyroid stimulating hormone(tsh)level with pregnancy outcome in women undergoing in vitro fertilization or intracytoplasmic sperm injection[J]. Reproduction & Contraception, 2012, 32(1): 17-23.
[13]  赵建新, 张弛, 刘荫华, 等. 120例分化型甲状腺癌随访8年的预后因素分析[J]. 中国癌症杂志, 2013, 23(1):51-54. ZHAO Jianxin, ZHANG Chi, LIU Yinhua, et al. Prognosis factors analysis of 120 cases differentiated thyroid cancer after follow-up of 8 years[J]. China Oncology, 2013, 23(1):51-54.
[14]  Cutting R, Morroll D, Roberts SA, et al. Elective single embryo transfer: guidelines for practice British Fertility Society and Association of Clinical Embryologists[J]. Human Fertility, 2008, 11(3):131-146.
[15]  Takagi H, Mitsumori K, Onodera H, et al. Improvement of a two—stage carcinogenesis model to detect modifying effects of endocrine disrupting chemicals on thyroid carcinogenesis in rats[J]. Cancer Lett, 2002, 178(1): 1-9.
[16]  Xhaard C, Rubino C, Clero E, et al. Menstrual and reproductive factors in the risk of differentiated thyroid caricionma in young women in France: a population-basted case-control study[J]. Am J Epidemiol, 2014, 180(10): 1007-1017.
[17]  Kabat GC, Kim MY, Wactawski-Wende J, et al. Mensturual and reproductive factors, exogenous hormone use, and risk of thyroid carcinoma in postmenopausal women[J]. Cancer Causes Control, 2012, 23(12): 2031-2040.
[18]  Althuis MD, Scoccia B, Lamb EJ, et al. Melanoma, thyroid, cervical and colon cancer risk after use of fertility drugs[J]. Am J Obstel Gynecol, 2005, 193(1): 668-674.
[19]  Pfeifer S, Butts S, Dumesic D, et al. Fertility drugs and cancer: a guideline[J]. Fertil Stetil, 2016, 106(7): 1617-1626.
[20]  He H, Jing S, Gong F, et al. Effect of thyroid autoimmunity perse on assisted reproduction treatment outcomes: a meta-analysis[J]. Taiwanese Journal of Obstetrics and Gynecology, 2016, 55(2): 159-165.
[21]  Mannisto T, Mendola P, Grewal J, et al. Thyroid diseases and adverse pregnancy outcome in a contemporary US cohort[J]. J Clin Endocrionl Metab, 2013, 98(7): 2725-2733.
[22]  景蓉, 李秀琴. 妊娠期甲状腺功能减退与妊娠期糖尿病对妊娠结局的影响及相关性分析[J]. 解放军医药杂志, 2017, 29(8): 66-71. JING Rong, LI Xiuqin. Relationship between hypothyroidism and gestational diabetes mellitus and their effects on pregnancy outcome[J]. Medical & Pharmaceutical Journal of Chinese Peoples Liberation Army, 2017, 29(8): 66-71.
[23]  张玉花, 黄德胜, 方琳, 等. 妊娠甲状腺功能减退症与妊娠期高血压疾病关系分析[J]. 数理医药学杂志, 2017, 30(11): 1595-1597. ZHANG Yuhua, HUANG Desheng, FANG Lin, et al. Analysis of the relationship between hypothyroidism in pregnancy and hypertensive disorder complicating pregnancy[J]. Journal of Mathematical Medicine, 2017, 30(11):1595-1597.
[24]  Bamberg C, Fotopoulou C, Neissner P, et al. Maternal characteristics and twin gestation outcomes over 10 years: impact of conception methods[J]. Fertil Steril, 2012, 98(1): 95-101.
[25]  张为远, 侯磊. 中国大陆剖宫产状况大数据调查的启示[J]. 中国实用妇科与产科杂志, 2018, 34(1): 38-40.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133